Estrogen has an anti-obesity effect and plays an important role in improving cardiometabolic
disorders. Weight loss and reduction in calorie intake impede the development of obesity …

Obesity and menopause lead to cardiovascular diseases. Calorie restriction (CR) can
modulate estrogen deficiency and obesity-related cardiovascular diseases. The protective …

Postmenopausal women tend to have a higher risk in developing obesity and thus metabolic
syndrome. Recently we could demonstrate that physical activity and estrogen replacement …

Women have a lower incidence of cardiovascular diseases (CVD) than men at a similar age
but have an increased incidence of CVD and metabolic syndrome after menopause …

Aims: Obesity is associated with insulin resistance, liver steatosis and low‐grade
inflammation. The role of oestrogen in sex differences in the above co‐morbidities is not fully …

Estrogen replacement therapy reduces the incidence of type 2 diabetes in postmenopausal
women; however, the mechanism is unknown. Therefore, the aim of this study was to …

The aim of the present study was to investigate the cardiac biomarker changes in
experimental bilateral ovariectomized (OVX) rats in addition to evaluating the role of …

Estrogen receptor α (ERα) and estrogen receptor β (ERβ) play important roles in
cardiovascular disease (CVD) prevention. Recently, these estrogen receptors were …

Metabolic syndrome (MBS), a cluster of metabolic abnormalities and visceral fat
accumulation, increases cardiovascular risks in postmenopausal women. In addition to …

Objective To study the potential mechanisms via which estrogen exerts its effects on the
insulin sensitivity in mice. Methods Totally 36 female C57BL/6J mice aged 6 weeks were …